Field Notes
Field Notes #11: Who Gets Paid for the Root?
Gabon wants a share of the ibogaine boom. New reporting exposes the distance between paying for bark and sharing the value created afterward.
Cultural reporting on cannabis, psychedelics, and plant medicine from The Alkaloid.
Field Notes
Gabon wants a share of the ibogaine boom. New reporting exposes the distance between paying for bark and sharing the value created afterward.
Field Notes
Cannabis-friendly social spaces need more than a place to consume. St. Louis offers a look at the work of hosting.
Field Notes
THC drinks borrow the rituals of a night out. Familiar packaging does not make the intoxicant familiar.
newsletter
Cannabis gets an official place in the event program. What two upcoming events promise, and what a small music study can actually tell us.
newsletter
A new cannabis genetics paper cataloged 227 volatile terpenes across six cultivars. The fun part is what those compounds reveal about flower, genes, and why your nose keeps finding more than a THC label can say.
newsletter
Past-month cannabis use among Minnesota teens fell from 13% to 5% across twelve years of steadily looser law, and the predicted spike never came. The decline also never reached Native, LGBTQ+ or low-income students, who were three times more likely to use in 2013 and still are today.
Field Notes
While psychedelic mushrooms fight for legal status, their boring cousins quietly became a near-$85 billion wellness industry. What the science on lion's mane and reishi actually shows — and where the marketing gets ahead of it.
newsletter
Humans have used peyote for 5,700 years, yet mescaline is the psychedelic neuroscience knows least. A new Northeastern brain scan shows the oldest trip has a signature all its own — and Big Pharma just bet up to $3.8B on its molecular cousins.
newsletter
For years, home growers prized a potent magic mushroom called Natal Super Strength. Nobody had ever named it. New DNA work shows it is a separate species, and its family tree pushes the origins of the world's favorite psychedelic mushroom back more than a million years.
newsletter
What if the trip was never the point? A new class of compounds promises the brain-rewiring of psychedelics without the hallucination, and the first non-tripping antidepressant is heading for trials you can run from your own couch.
newsletter
Scientists finally caught the munchies in the act. A new study shows cannabis turns up the brain's reward for food, spikes the hunger hormone, and sharpens taste. The same circuit could feed people who can't eat.
newsletter
Psychedelic science spent sixty years studying the young. A new UC Berkeley study finally hands the eye mask to people between 60 and 85 — and asks whether an old brain can still change its mind.